Taken together, these findings suggest that FUS-DDIT3 could prevent the development of committed adipocytic precursors in liposarcoma through the interference with PPARγ and C/EBPα expression, two transcription factors with a critical role in adipogenesis. The gene discussed is CEBPA; the disease is liposarcoma.